Amrutanjan Health Care DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.74×	0.74×	0.74×	0.73×	0.74×
	1.09×	1.12×	1.34×	1.37×	1.37×
	13.1%	13.8%	11.4%	10.7%	10.3%
	1.08×	1.08×	1.15×	1.16×	1.07×
	1.37×	1.37×	1.29×	1.27×	1.25×
	15.7%	17.1%	16.7%	15.7%	14.0%
	16.6%	16.6%	16.5%	15.5%	14.3%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

AMRUTANJAN₹493.20

Amrutanjan Health Care Limited

· Pharma & Health

₹ CrorePeersJAGSNPHARM NGLFINE SIGACHI LINCOLN SYNCOMF THEMISMED HESTERBIOMcap ₹1,426 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.74	0.73	0.74	0.74	0.74
Interest Burden (Pretax/EBIT) ×	1.37	1.37	1.34	1.12	1.09
EBIT Margin %	10.32	10.72	11.44	13.80	13.06
Asset Turnover ×	1.07	1.16	1.15	1.08	1.08
Financial Leverage (Assets/Equity) ×	1.25	1.27	1.29	1.37	1.37
ROE (5-step product, year-end total equity) %	13.98	15.75	16.69	17.11	15.66
ROE (owners' profit / average owners' equity) %	14.33	15.53	16.53	16.62	16.62

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.